SPAS(SH:603168) Shang Hai Zheng Quan Bao·2025-06-20 20:26Summary of Key Points Core Viewpoint - The announcement details the share reduction results of Zhejiang Shapuaisi Pharmaceutical Co., Ltd. by its shareholder Shanghai Jingxing Industrial Investment Co., Ltd. The reduction was executed through a centralized bidding process, resulting in a decrease in the shareholder's stake in the company. Group 1: Shareholder Holding Situation - As of March 18, 2025, Shanghai Jingxing held 16,150,426 shares of Shapuaisi, accounting for 4.2962% of the total share capital [1] - Following the share reduction, as of June 20, 2025, Shanghai Jingxing's holdings decreased to 12,982,726 shares, representing 3.4535% of the total share capital of 375,925,005 shares [1] Group 2: Implementation of Reduction Plan - The reduction plan was executed within the specified timeframe from March 21, 2025, to June 20, 2025, during which Shanghai Jingxing reduced its holdings by 3,167,700 shares [2] - The actual reduction met the previously disclosed minimum reduction quantity and was consistent with the announced reduction plan [2]